Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Tegatrabetan (BC2059) is an antagonist of β-Catenin
LCZ696 could inhibit the expression of ANP
InChi: InChI=1S/C21H15ClF4N4O3
Ba/F3-TEL-TRKC (IC50 of 3
RAF265 enafil dihydrochloride Tegatrabetan (BC2059) is an antagonistCHIR 265 is an orally bioavailable small molecule with potential antineoplastic activity. CHIR 265 binds and inhibits Raf kinases, which may result in a reduction of tumor cell growth and proliferation, and tumor cell death. In addition, this agent inhibits vascular endothelial growth factor receptor type 2 (VEGFR 2), thereby disrupting tumor angiogenesis. Raf kinases are critical enzymes in the Ras Raf MEK ERK signaling pathway and are frequently
US$ 52.00
US$ 54.00
US$ 1247.50
US$ 137.50
US$ 54.00
US$ 64.00
US$ 2125.00
US$ 1375.00